ʻO ka maʻi o Crohn (CD) he maʻi ʻaʻai ʻokoʻa ʻole, ʻaʻole maopopo ka etiology o ka maʻi o Crohn, i kēia manawa, pili ia i ka genetic, maʻi, nā mea kūlohelohe a me nā mea immunologic.

I nā makahiki i hala iho nei, ua ulu mau ka maʻi o Crohn. Mai ka paʻi ʻia ʻana o ka paʻi mua o nā alakaʻi hoʻomaʻamaʻa, ua nui nā loli i hana ʻia i ka ʻike a me ka mālama ʻana i nā maʻi me ka maʻi o Crohn. No laila i ka makahiki 2018, ua hōʻano hou ka American Society of Gastroenterology i ke alakaʻi o ka maʻi o Crohn a waiho i kekahi mau manaʻo i ka maʻi a me ka mālama ʻana, i hoʻolālā ʻia e hoʻoponopono maikaʻi i nā pilikia olakino pili i ka maʻi o Crohn. Manaʻo ʻia e hiki i ke kauka ke hoʻohui i nā alakaʻi me nā pono o ka mea maʻi, nā makemake a me nā waiwai i ka wā e alakaʻi ai i nā hoʻoholo lāʻau lapaʻau i mea e mālama pono ai i nā maʻi me ka maʻi o Crohn.

Wahi a ka American Academy of Gastroenteropathy (ACG): ʻO Fecal calprotectin (Cal) kahi hōʻailona hoʻāʻo pono, hiki iā ia ke kōkua i ka hoʻokaʻawale ʻana ma waena o ka maʻi ʻeha ʻeha (IBD) a me ka maʻi irritable bowel syndrome (IBS). Eia kekahi, ua hōʻike kekahi mau haʻawina e ʻike ʻo Fecal calprotectin i ka IBD a me ka maʻi maʻi colorectal, hiki i ka sensitivity o ka ʻike ʻana i ka IBD a me IBS ke hiki i 84% -96.6%, hiki i ka kikoʻī ke hiki i 83% -96.3.

E ʻike hou aku e pili anaFecal calprotectin(Cal).